Navigation Links
ABRISA Appoints Jim Veler as President/CEO
Date:9/10/2009

SANTA PAULA, Calif., Sept. 10 /PRNewswire/ -- Abrisa, Inc., a global leader in industrial glass fabrication products and precision thin film optical coatings, recently named industry veteran Jim Veler as President and Chief Executive Officer. The appointment became effective June 1, 2009.

Prior to joining Abrisa, Mr. Veler was Vice President and General Manager of Agilent Technologies' Wireless Manufacturing Organization (Santa Rosa, CA). His duties included the management of 1600 employees and full responsibility for the manufacturing operations of two semiconductor fabs as well as Agilents' Aerospace Defense Systems' business.

Jim Veler notes, "My vision is to transform Abrisa from its roots as a respected global leader of high-volume industrial glass fabrication to an innovator in providing precision optical product solutions. While we will be focusing on several markets, we are targeting substantial growth in four key segments: defense, medical, display, and lighting. Abrisa has gained tremendous momentum with our two recent acquisitions and we plan to acquire at least one more company to help us better serve these strategic markets."

"What makes Veler an excellent choice for the Abrisa helm is his vast experience in the thin film industry," says Mr. Tom Portland, Chairman of the Abrisa Board. He adds, "Jim rose to the level of Vice President and General Manager of the Custom Optics Products Group, the legacy Optical Coating Laboratory Inc. (OCLI) business, now part of JDS Uniphase (Santa Rosa, CA). In his role at OCLI, he managed all aspects of the business including sales, marketing, R&D, business development, and operations. Jim brings his experience at OCLI to his new role here at Abrisa. Jim has already taken his first steps towards achieving his vision by hiring two industry-renowned sales managers. Jim Hooker (previously with Deposition Sciences and Optical Coating Laboratories) joined Abrisa to lead the eastern sales region and Kevin Liddane (previously with Oerlikon) joined to lead the western region. With a combined industry experience base of more than 70 years between them, Abrisa is poised to make an impact in the precision optics industry."

"Abrisa is dedicated to offering customized optical product solutions with the best-in-industry quality, reliability, and customer service," Veler continues. "I want Abrisa to earn its business every step of the way by demonstrating that Abrisa is a company that always puts its customers first. Strong leadership, industry experience, and a humble approach will set Abrisa apart in the market, and I am very excited about the opportunity that lies ahead for Abrisa and our customers."

Abrisa (http://www.abrisa.com - Santa Paula, CA) manufactures high-quality glass products and thin film optical coatings. Offering completely integrated glass fabrication and precision coating solutions from UV to Far IR, the company also provides OEM custom engineering, design, and support services for markets such as biological/life sciences, medical, military/defense, aerospace, topical, outdoor and avionics display, entertainment lighting, medical and interior architectural lighting and projection display industries. Abrisa's customized glass fabrication includes glass strengthening and coatings, screen printing, busbar, precision machining, cutting and edging services, and clean room specialty packaging. Abrisa recently acquired Sycamore Glass Components (Sycamore, IL), a glass manufacturing facility specializing in fabricating advanced technology, military, display and optical products, while specializing in smaller, custom projects. In 2007, the company also acquired ZC&R Coatings for Optics (Torrance, CA) to provide innovative and reliable precision optical coatings and components as part of the Abrisa family of products.

    ABRISA
    Complete Glass & Thin Film Coatings Solutions
    200 S. Hallock Drive
    Santa Paula, CA  93060
    Contact: Jim Veler, President, CEO
    Phone: 1.877.622.7472 (1.877.6.ABRISA)
    Fax: 1.805.525.8604
    E-mail: jveler@abrisa.com
    Web Site:http://www.abrisa.com

    Media Contact:

    Marlene Moore
    Smith Miller Moore: 818.708.1704
    Email: Marlene@smm-ads.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Abrisa, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio Strategy
2. Hovione Appoints Terry Lambe to its Board of Directors
3. Sechrist Increases Focus on International Markets; Appoints William Preuit Senior Vice President
4. China Biologic Products Appoints Director of Research and Development
5. PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director
6. iPierian Appoints Dr. Matthew J. Plunkett as Chief Financial Officer
7. Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development
8. ERT Appoints New Associate Director of Business Development - Japan
9. NeurogesX Appoints New Board Director and Audit Committee Chairman
10. Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer
11. Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  ArmaGen, Inc., ... groundbreaking therapies to treat severe neurological disorders, today ... treated with AGT-181, the company,s investigational therapy for ... known as mucopolysaccharidosis type I, or MPS I). ... proof-of-concept (POC) study, presented today at the 13 ...
(Date:2/16/2017)... , Feb. 16, 2017   Biostage, Inc. ... "Company"), a biotechnology company developing bioengineered organ implants to ... bronchus and trachea, announced today the closing on February ... 20,000,000 shares of common stock and warrants to purchase ... of $8.0 million. The offering was priced at $0.40 ...
(Date:2/16/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, today announced it has completed ... into a $5 million credit facility with Silicon ... capital for general corporate purposes to further Dermata,s ... of serious diseases treated by dermatologists.   ...
(Date:2/16/2017)... 2017  Windtree Therapeutics, Inc. (Nasdaq: ... aerosolized KL4 surfactant therapies for respiratory diseases, announced ... showed that aerosolized KL4 surfactant reduced lung inflammation ... animal model. The Company believes that these preclinical ... that supports the role of KL4 surfactant as ...
Breaking Biology Technology:
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
(Date:2/2/2017)... , Feb. 2, 2017  EyeLock LLC, a ... a new white paper " What You Should Know ... problem of ensuring user authenticity is a growing concern. ... authentication of users. However, traditional authentication schemes such as ... Biometric authentication offers an elegant solution to ...
Breaking Biology News(10 mins):